Concluding the year at the San Antonio Breast Cancer Symposium, scheduled for December 5th – 9th, 2023, at the Henry B. Gonzalez Convention Center in San Antonio, Texas, USA, holds significant importance for us within the scientific community.
Notably, this year marked a moment of distinction for #MEDSIR, with our five selected studies:
A rapid-fire mini-oral presentation for PARSIFAL-LONG, a PARSIFAL substudy, two spotlight poster sessions for ATRACTIB and DEBBRAH Cohort 5, and two regular poster sessions for MiRaDoR, a study conducted with our strategic partner, Grupo Oncoclínicas and a exploratory study of PARSIFAL trial in collaboration with REVEAL GENOMICS, S.L.
We invite you to explore them in detail and discover the latest advancements in breast cancer.
https://lnkd.in/d9K-5XYe
#breastcancer #oncology #clinicalresearch #clinicaltrials #SABCS23
We are delighted to inform you that your post has been successfully published on Oncodaily. Thank you for sharing such valuable content. https://oncodaily.com/blog/84221.html